Relay Therapeutics: The Quant King, the Drug Hunter, and the Quest to Unlock New Cures
A strategic external communications partner building the brands of an elite group of life sciences companies
Capabilities
Executive Counsel
Key Message Development
Spokespeople Training
Unparalleled Media Relations
Executive Visibility & Speaking Opportunities
Website and Brand Development
Crisis Management
WE WORK WITH CLIENTS THROUGH MANY PHASES AND EXPERIENCES
- Company launches, private companies, publicly traded companies
- Financings, business development agreements, IPOs/reverse mergers, M&A
- Every phase of drug/device development, medical meeting and journal publication
- Drug/product approval (in U.S. and abroad), launch and commercial support
- Navigating various moments of adversity – clinical trial setbacks, FDA advisory committee meetings, approvable letters/CRLs, and unfortunately, many more!
Foundation Medicine: Cambridge biotech’s cancer test turns out to be a ‘lifesaver’
Loxo Oncology: Loxo CEO on genetically targeted cancer drugs
Third Rock Ventures and Casdin Capital: Here’s How Biotechs Plan To Attack Cancer, Other Diseases In 2019
Beam Therapeutics: Harvard and MIT launch gene editing company
